Palatin Technologies rises on higher Q4 prelim product revenue‍

Palatin Technologies

11/07/2023 15:12

** Shares of specialty drugmaker Palatin Technologies Inc
 PTN.A  up 1.8% at $2.22 
    ** Co posts Q4 prelim Vyleesi product revenue results; Gross
product rev. was $4.1 mln, up 78% from a year earlier
    ** For Vyleesi, Q4 prelim net product revenue was $1.7 mln,
up 122% 
    ** Vyleesi is a treatment for premenopausal women with
acquired, generalized hypoactive sexual desire disorder
    ** PTN shares down 13.28% YTD


 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))